Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in Previously Treated B-Cell CLL or PLL
NCT00098371Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Apr 2005
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PLL), sponsored by National Cancer Institute. Started Apr 2005; status: terminated.
02
Drugs
alvocidib
03
Conditions
chronic lymphocytic leukemia (CLL)prolymphocytic leukemia (PLL)
Beyond the preview
Go deeper on NCT00098371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098371.